Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#349 most reported symptom for this vaccine
Tachypnoea has been reported 9 times in association with Influenza, Seasonal (Flucelvax Quadrivalent) vaccination in VAERS. This represents 0.1% of all 8,852 reports for this vaccine.
Among these reports, 1 mentioned death (11.11%) and 5 involved hospitalization (55.6%).
Tachypnoea is the #349 most frequently reported symptom for Influenza, Seasonal (Flucelvax Quadrivalent) out of 844 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 9 reports of Tachypnoea after Influenza, Seasonal (Flucelvax Quadrivalent) vaccination may seem alarming, but context is critical.
The 11.11% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.